Surgical hardware and digital intelligence are converging.
In particular, we are watching ortho/spine market reach an inflection point, driven by the continual migration to ASCs and tighter reimbursement models.
To survive this economic reality, startups must be operational, not merely theoretical.
In the past, spine care have been constrained by two major bottlenecks: heavy, infection-prone reusable metal trays in the OR, and reactive, post-symptomatic diagnostic models in the clinic. As the orthopedic field enters a transformative era marked by outpatient shifts and predictive digital health, the focus is pivoting toward pre-sterilized single-use efficiency and markerless early-detection AI.
Today I want to highlight Xenco Medical.
San Diego-based Xenco Medical is tackling these high-stakes challenges head-on. Fresh off unveiling its XenVision AI platform at SIGGRAPH on July 20, 2026, the company is perfectly positioned to disrupt both the spine hardware market and the rapidly expanding musculoskeletal AI diagnostics space.
Xenco Medical has perfectly mapped the collision between clinical need and economic viability:
The Hardware Problem: Reusable trays introduce overhea...
